Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2024-12-16
VOLUNTARY ANNOUNCEMENT - ENTERING INTO T-CELL ENGAGER DISCOVERY COLLABORATION WITH CANDID
2024-12-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
2024-11-28
Next Day Disclosure Return
2024-11-25
Next Day Disclosure Return
2024-11-22
Next Day Disclosure Return
2024-11-18
Next Day Disclosure Return
2024-11-11
Next Day Disclosure Return
2024-11-08
Next Day Disclosure Return
2024-11-08
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF INVESTIGATIONAL NEW DRUG APPLICATION FOR HBM9378/SKB378 (ANTI-TSLP) FOR COPD TO THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
2024-11-07
Next Day Disclosure Return
2024-11-06
Next Day Disclosure Return
2024-11-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31October 2024
2024-11-04
Next Day Disclosure Return
2024-11-01
Next Day Disclosure Return
2024-10-31
Next Day Disclosure Return
2024-10-30
Next Day Disclosure Return
2024-10-29
Next Day Disclosure Return
2024-10-24
APPOINTMENT OF JOINT COMPANY SECRETARY, WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES, AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.10(2) AND 3.21 OF THE LISTING RULES
2024-10-24
Next Day Disclosure Return
2024-10-10
Next Day Disclosure Return
1
···
9
10
···
21
Jump